NASDAQ
Abattis Bioceuticals Corp. (ATTBF) has a interest coverage ratio of -80.16x as of Friday, May 29, 2026. This represents a 86.28% increase compared to its 12-month average of -584.45x. The interest coverage ratio measures how easily a company can pay interest on its outstanding debt from operating earnings.
No price data available for this timeframe.